SCHEMBL30438344

SCHEMBL30438344

CNC(=O)c1ncccc1Oc1ccc(N)c(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCK P35557 4/20 0.44
BRAF P15056 5/20 0.42
HDAC1 Q13547 5/20 0.42
HDAC3 O15379 4/20 0.41
HDAC4 P56524 4/20 0.41
HDAC7 Q8WUI4 4/20 0.41
HDAC2 Q92769 4/20 0.41
HDAC10 Q969S8 4/20 0.41
HDAC11 Q96DB2 4/20 0.41
HDAC8 Q9BY41 4/20 0.41
HDAC6 Q9UBN7 4/20 0.41
HDAC9 Q9UKV0 4/20 0.41
HDAC5 Q9UQL6 4/20 0.41
GRM4 Q14833 1/20 0.40
CARM1 Q86X55 1/20 0.39
PRMT6 Q96LA8 1/20 0.39
MET P08581 3/20 0.37
SCN9A Q15858 1/20 0.37
KDR P35968 1/20 0.36
PYGL P06737 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28026579 1.00 GCK (0.44) GCKBRAFHDAC1HDAC3HDAC4
SCHEMBL27711531 0.85 SMN1; SMN2 (0.44) GCKGRM4CARM1PRMT6MET
SCHEMBL31465417 0.85 KDM4E (0.40) GCKGRM4CARM1PRMT6MET
SCHEMBL31255792 0.85 GCK (0.41) GCKBRAFHDAC1HDAC3HDAC4
SCHEMBL29614703 0.82 MEN1 (0.45) BRAFHDAC1HDAC3HDAC4HDAC7
SCHEMBL4252286 0.82 MEN1 (0.45) BRAFHDAC1HDAC3HDAC4HDAC7
SCHEMBL30834059 0.78 GCK (0.38) GCKCARM1PRMT6METSCN9A
SCHEMBL29396481 0.77 KDR (0.58) BRAFMETKDR
SCHEMBL400592 0.77 KDR (0.58) BRAFMETKDR
Water SCHEMBL2991434 0.76 KDR (0.57) BRAFMETKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820217-A Synthesis method of regorafenib key intermediate 南京亿华药业有限公司 2024-04-05 CN disclosed
CN-117820217-A Synthesis method of regorafenib key intermediate 南京亿华药业有限公司 2024-04-05 CN disclosed
CN-114920689-B Preparation method of regorafenib intermediate 石药集团中奇制药技术(石家庄)有限公司 2024-04-02 CN disclosed
CN-116203178-A Method for detecting genotoxic impurities in regorafenib intermediate by UPLC-MS/MS 上海博悦生物科技有限公司 2023-06-02 CN disclosed